Fraction-variant VMAT planning for patients with complex gynecological and head-and-neck cancer

TL;DR

This study introduces a novel fraction-variant VMAT planning method that improves dosimetric quality and reduces delivery time for complex cancer cases by optimizing different plans across fractions.

Contribution

It develops a direct aperture optimization algorithm for simultaneous multi-plan optimization across fractions, enhancing plan quality and efficiency.

Findings

Fraction-variant treatments improved target coverage.

Reduced dose to organs-at-risk.

Delivery time decreased significantly.

Abstract

Background and Purpose: Increasing the number of arcs in volumetric modulated arc therapy (VMAT) allows for better intensity modulation and may improve plan quality. However, this leads to longer delivery times, which may cause patient discomfort and increase intra-fractional motion. In this study, it was investigated whether the delivery of different VMAT plans in different fractions may improve the dosimetric quality and delivery efficiency for the treatment of patients with complex tumor geometries. Materials and Methods: A direct aperture optimization algorithm was developed which allows for the simultaneous optimization of different VMAT plans to be delivered in different fractions, based on their cumulative physical dose. Each VMAT plan is constrained to deliver a uniform dose within the target volume, such that the entire treatment does not alter the fractionation scheme and is robust against inter-fractional setup errors. This approach was evaluated in-silico for ten patients with gynecological and head-and-neck cancer. Results: For all patients, fraction-variant treatments achieved better target coverage and reduced the dose to critical organs-at-risk compared to fraction-invariant treatments that deliver the same plan in every fraction, where the dosimetric benefit was shown to increase with the number of different plans to be delivered. In addition, 1-arc and 2-arc fraction-variant treatments could approximate the dosimetric quality of 3-arc fraction-invariant treatments, while reducing the delivery time from 180 s to 60 s and 120 s, respectively. Conclusions: Fraction-variant VMAT treatments may achieve excellent dosimetric quality for patients with complex tumor geometries, while keeping the delivery time per fraction viable.